Correlation Between Dominari Holdings and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dominari Holdings and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Dominari Holdings and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and Apellis Pharmaceuticals.
Diversification Opportunities for Dominari Holdings and Apellis Pharmaceuticals
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dominari and Apellis is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dominari Holdings and Apellis Pharmaceuticals
Given the investment horizon of 90 days Dominari Holdings is expected to generate 1.69 times more return on investment than Apellis Pharmaceuticals. However, Dominari Holdings is 1.69 times more volatile than Apellis Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 131.00 in Dominari Holdings on October 20, 2024 and sell it today you would lose (8.00) from holding Dominari Holdings or give up 6.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dominari Holdings vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Dominari Holdings |
| Apellis Pharmaceuticals |
Dominari Holdings and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dominari Holdings and Apellis Pharmaceuticals
The main advantage of trading using opposite Dominari Holdings and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Dominari Holdings vs. CytomX Therapeutics | Dominari Holdings vs. Instil Bio | Dominari Holdings vs. Spero Therapeutics | Dominari Holdings vs. Assembly Biosciences |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |